NEU 3.15% $21.27 neuren pharmaceuticals limited

Very encouraging for the Rett's families and potentially other...

  1. 138 Posts.
    Very encouraging for the Rett's families and potentially other application to other neuro conditions moving forward, but still not convinced the results are enough for a really favourable deal or a fire under the SP. They are still learning much about the pharmacokinetics of the medication, but are making positive advancements.

    "Since it shows the potential of neurobiologically-based drugs for the treatment of Rett syndrome and other neurodevelopmental disorders" is potentially a game changer, but this requires much further study. Will pharma pay up for this potential combined with the what we know in Rett's now, or will they want further insight...
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$21.27
Change
0.650(3.15%)
Mkt cap ! $2.718B
Open High Low Value Volume
$20.84 $21.56 $20.76 $7.760M 364.5K

Buyers (Bids)

No. Vol. Price($)
2 1378 $21.24
 

Sellers (Offers)

Price($) Vol. No.
$21.29 218 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.